Zeqian Yu

430 total citations
17 papers, 361 citations indexed

About

Zeqian Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zeqian Yu has authored 17 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Zeqian Yu's work include Cancer Research and Treatments (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and MicroRNA in disease regulation (3 papers). Zeqian Yu is often cited by papers focused on Cancer Research and Treatments (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and MicroRNA in disease regulation (3 papers). Zeqian Yu collaborates with scholars based in China, United States and Canada. Zeqian Yu's co-authors include Jiahua Zhou, Robert M. Hoffman, Jiahua Zhou, Lishan Wang, Long Ren, Junying Wang, Liang Hu, Michael Bouvet, Jie Zheng and Zhangjun Cheng and has published in prestigious journals such as Oncotarget, Journal of Materials Chemistry B and Journal of Surgical Research.

In The Last Decade

Zeqian Yu

17 papers receiving 354 citations

Peers

Zeqian Yu
Zeqian Yu
Citations per year, relative to Zeqian Yu Zeqian Yu (= 1×) peers Lianji Wen

Countries citing papers authored by Zeqian Yu

Since Specialization
Citations

This map shows the geographic impact of Zeqian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeqian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeqian Yu more than expected).

Fields of papers citing papers by Zeqian Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeqian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeqian Yu. The network helps show where Zeqian Yu may publish in the future.

Co-authorship network of co-authors of Zeqian Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zeqian Yu. A scholar is included among the top collaborators of Zeqian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeqian Yu. Zeqian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lu, Miao, Pengfei Shen, Siyuan Tan, et al.. (2025). TGFBI promotes EMT and perineural invasion of pancreatic cancer via PI3K/AKT pathway. Medical Oncology. 42(6). 181–181. 1 indexed citations
2.
Zhu, Qian, Zhengqing Lei, Chang Xu, et al.. (2023). LncRNA HClnc1 facilitates hepatocellular carcinoma progression by regulating PKM2 signaling and indicates poor survival outcome after hepatectomy. Cancer Medicine. 12(13). 14526–14544. 11 indexed citations
3.
Yu, Zeqian, et al.. (2023). mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 31(4). 495–503. 6 indexed citations
4.
Yu, Zeqian, et al.. (2021). Effects of Arsenic Trioxide-Loaded PLGA Nanoparticles on Proliferation and Migration of Human Vascular Smooth Muscle Cells. Journal of Nanomaterials. 2021. 1–8. 1 indexed citations
5.
Yu, Zeqian, et al.. (2021). Allicin depresses biological activities of pancreatic cancer cells by regulating miRNA-339-5p/ZNF-689 axis. Archives of Medical Science. 3 indexed citations
6.
Li, Haifeng, Peng Xie, Zheng Zhang, et al.. (2021). Role of long intergenic non-protein coding RNA 00152 in pancreatic cancer glycolysis via the manipulation of the microRNA-185-5p/Krüppel-like factor 7 axis. Journal of Cancer. 12(21). 6330–6343. 8 indexed citations
7.
Wang, Maonan, Zeqian Yu, Huan Feng, et al.. (2019). In situbiosynthesized gold nanoclusters inhibiting cancer developmentviathe PI3K–AKT signaling pathway. Journal of Materials Chemistry B. 7(35). 5336–5344. 20 indexed citations
8.
Yu, Zeqian, et al.. (2019). miRNA-339-5p Plays an Important Role in Invasion and Migration of Pancreatic Cancer Cells. Medical Science Monitor. 25. 7509–7517. 29 indexed citations
10.
Yu, Zeqian, et al.. (2017). Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation. Oncotarget. 8(38). 63461–63483. 101 indexed citations
11.
Wang, Lishan, Yang Yang, Fangfang Hu, et al.. (2016). Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway. Oncotarget. 7(25). 38539–38550. 32 indexed citations
12.
Zhou, Jiahua, et al.. (2013). Folate-chitosan-gemcitabine core-shell nanoparticles targeted to pancreatic cancer.. PubMed. 25(5). 527–35. 32 indexed citations
13.
Yu, Zeqian, Jiahua Zhou, & Robert M. Hoffman. (2012). Lentivirus-Based DsRed-2-Transfected Pancreatic Cancer Cells for Deep In Vivo Imaging of Metastatic Disease. Methods in molecular biology. 872. 69–83. 2 indexed citations
14.
Zhou, Jiahua, et al.. (2011). Resveratrol induces apoptosis in pancreatic cancer cells.. PubMed. 124(11). 1695–9. 39 indexed citations
15.
Zhou, Jiahua, Liang Hu, Zeqian Yu, et al.. (2010). Marker Expression in Circulating Cancer Cells of Pancreatic Cancer Patients. Journal of Surgical Research. 171(2). 631–636. 50 indexed citations
16.
Yu, Zeqian, et al.. (2009). [Establishment of red fluorescent protein orthotopic transplantation nude mice metastasis model of pancreatic cancer and whole-body fluorescent imaging].. PubMed. 47(14). 1092–5. 1 indexed citations
17.
Zhou, Jiahua, Zeqian Yu, Liang Hu, et al.. (2008). Lentivirus-Based DsRed-2-Transfected Pancreatic Cancer Cells for Deep In Vivo Imaging of Metastatic Disease. Journal of Surgical Research. 157(1). 63–70. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026